Lucid Diagnostics Inc.
LUCD
$1.01
$0.022.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.49% | -56.45% | -134.22% | 83.50% | -133.15% |
| Total Depreciation and Amortization | 6.22% | -5.00% | -0.90% | 0.45% | -0.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.38% | 14,783.33% | 99.57% | -136.09% | 3,054.25% |
| Change in Net Operating Assets | -3,706.67% | 93.50% | 2.40% | 47.87% | -242.56% |
| Cash from Operations | 3.79% | -15.47% | -3.26% | 15.37% | -26.28% |
| Capital Expenditure | -321.57% | -82.14% | -12.00% | 73.12% | 64.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -321.57% | -82.14% | -12.00% | 73.12% | 64.09% |
| Total Debt Issued | -- | -- | -- | -100.00% | -98.33% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 275,100.00% | -99.99% | 64.83% | 9.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 274,250.00% | -99.99% | 64.83% | 6.61% | -14.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.92% | -177.90% | 175.43% | 104.34% | -63.40% |